top of page
Executive Spotlights

Paragon spinout Apogee Therapeutics emerges with $169 million to expand team

Waltham, MA, December 7, 2022 (PRNewswire) -- Paragon Therapeutics, a biotechnology company dedicated to discovering and developing best-in-class biologics for a range of diseases with high unmet need, today announced the launch of Apogee Therapeutics, LLC, its first spinout. Apogee is advancing a pipeline of product candidates discovered and developed at Paragon that have potential to reach millions of people living with inflammatory and immunological disorders.


Read full article here.

Recent Posts

See All

Santa Clara, CA, January 17, 2023 (RTTNews) -- Shockwave Medical, Inc. (SWAV) has entered into a definitive agreement to acquire Neovasc Inc. (NVCN). Shockwave will acquire all outstanding Neovasc s

Life Science Headlines
bottom of page